CSIMarket Company Name, Ticker, Industry, else..
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• EPS Net Y/Y Annual
Regencell Bioscience Holdings Limited  (NASDAQ: RGC)
 

RGC's EPS Net Growth by Quarter and Year

Regencell Bioscience Holdings Limited's EPS Net results by quarter and year

Download as CSV




RGC EPS Net (in $) FY 2025 FY 2024 FY 2023 FY 2022
4th Quarter December -0.72 -0.01 -0.02 0.00
3rd Quarter September 0.00 0.00 0.00 0.00
2nd Quarter June 0.00 0.00 0.00 0.00
1st Quarter March 0.00 0.00 0.00 0.00
FY   -0.72 -0.01 -0.02 0.00

RGCs Annual EPS Net
Regencell Bioscience Holdings Limited's EPS Net in the fiscal year 2025 $ -0.72
Regencell Bioscience Holdings Limited's EPS Net in the fiscal year 2023 $ -0.01
Regencell Bioscience Holdings Limited's EPS Net in the fiscal year 2022 $ -0.02
Regencell Bioscience Holdings Limited's EPS Net in the fiscal year 2021 $ 0.00
Regencell Bioscience Holdings Limited's EPS Net in the fiscal year 2017 $ 0.02




RGC EPS Net fourth quarter 2025 Y/Y Growth Comment
Regencell Bioscience Holdings Limited in the fourth quarter 2025 recorded EPS net loss of $ -0.72 .

According to the results reported in the fourth quarter 2025, Regencell Bioscience Holdings Limited achieved the best EPS Net growth in Legal Cannabis industry. While Regencell Bioscience Holdings Limited' s EPS Net no change of 0% ranks overall at the positon no. in the fourth quarter 2025.


RGC EPS Net ( Y/Y Growth %) 2025
 2024 2023 2022
4th Quarter December - - - -
3rd Quarter September - - - -
2nd Quarter June - - - -
1st Quarter March - - - -
FY   - - - -

Financial Statements
Regencell Bioscience Holdings Limited's fourth quarter 2025 EPS Net $ -0.72 RGC's Income Statement
Regencell Bioscience Holdings Limited's fourth quarter 2024 EPS Net $ -0.01 Quarterly RGC's Income Statement


RGC EPS Net (Quarter on Quarter Growth %)

 2025
 2024 2023 2022
4th Quarter December - - - -
3rd Quarter September - - - -
2nd Quarter June - - - -
1st Quarter March - - - -
FY (Year on Year)   - - - -


Go to entire RGC Income Statement >> Back to RGC Growth rate Comparisons >>


EPS Net fourth quarter 2025 Y/Y Growth Company Ranking
Within: No.
Legal Cannabis Industry #
Consumer Non Cyclical Sector #
Overall #

EPS Net Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 
EPS Net fourth quarter 2025 Y/Y Growth Company Ranking
Within: No.
Legal Cannabis Industry #
Consumer Non Cyclical Sector #
Overall #
EPS Net Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 

EPS Net by Quarter for the Fiscal Years 2022, 2023, 2024, 2025

Regencell Bioscience Holdings Limited's Q/Q EPS Net Growth


EPS Net Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


RGC's IV. Quarter Q/Q EPS Net Comment


EPS Net Q/Q Growth Company Ranking
Within: No.
Legal Cannabis Industry #
Consumer Non Cyclical Sector #
Overall #
EPS Net Q/Q Growth Company Ranking
Within: No.
Legal Cannabis Industry #
Consumer Non Cyclical Sector #
Overall #
EPS Net Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


RGC's IV. Quarter Q/Q EPS Net Comment


Regencell Bioscience Holdings Limited's 12 Months EPS Net Growth Year on Year


EPS Net TTM Growth

12 Months Ending
(Jun 30 2025)		 12 Months Ending
(Jun 30 2023)		 12 Months Ending
0		 12 Months Ending
0		 12 Months Ending
0
Cumulative EPS Net 12 Months Ending $ -0.72 $ -0.01 $ 0.00 $ 0.00 $ 0.00
Y / Y EPS Net Growth (TTM) - - - - -
Year on Year EPS Net Growth Overall Ranking # # # # #
Seqeuential EPS Net Change (TTM) - - - - -
Seq. EPS Net Growth (TTM) Overall Ranking # # # # #


Cumulative EPS Net growth Comment
Regencell Bioscience Holdings Limited' has realized cumulative trailing twelve months EPS net loss of $ -1 in the Jun 30 2025 period.
The business is worsening as the cumulative EPS net loss is inflating from $ -0.01 for the period from Jun 30 2023 to 0 and $ from the TTM period ending 0.

Regencell Bioscience Holdings Limited achieved highest trailing twelve month year on year EPS Net growth. While overall EPS Net growth ranking, remained unchanged compare to the previous quarter at no. .

EPS Net TTM Y/Y Growth Company Ranking
Within: No.
Legal Cannabis Industry #
Consumer Non Cyclical Sector #
Overall #

EPS Net TTM Y/Y Growth Statistics
High Average Low
0 %
 0 %
0 %
 


EPS Net TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #
Cumulative EPS Net growth Comment
Regencell Bioscience Holdings Limited' has realized cumulative trailing twelve months EPS net loss of $ -1 in the Jun 30 2025 period.
The business is worsening as the cumulative EPS net loss is inflating from $ -0.01 for the period from Jun 30 2023 to 0 and $ from the TTM period ending 0.

Regencell Bioscience Holdings Limited achieved highest trailing twelve month year on year EPS Net growth. While overall EPS Net growth ranking, remained unchanged compare to the previous quarter at no. .


EPS Net TTM Y/Y Growth Company Ranking
Within: No.
Legal Cannabis Industry #
Consumer Non Cyclical Sector #
Overall #

EPS Net TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 






Other EPS Net Growth
Legal Cannabis Industry EPS Net Growth Trends and Statistics
Consumer Non Cyclical Sector EPS Net Growth Statistics
EPS Net Growth Trends for overall market
RGC's EPS Net Growth Ratio versus Legal Cannabis Industry, Consumer Non Cyclical Sector and total Market
Highest Ranking EPS Net Growth
Lowest Ranking EPS Net Growth




Companies with similar EPS Net no change for the quarter ending Jun 30 2025 within Consumer Non Cyclical SectorY/Y Change %EPS Net for the quarter ending Jun 30 2025


About Regencell Bioscience Holdings Limited EPS Net Growth Rates (RGC), Current and Historic Growth - CSIMarket Analysis

How we calculate this

This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years). Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.

Last updated

  • Page updated:
  • Data lineage: SEC filings → XBRL parse → normalization CSIMarket.com Database → growth calculations.
  • Figures are derived from filed reports and may be restated; numbers are subject to revision.

Sources: the company’s SEC filings (XBRL/Inline XBRL) and CSIMarket.com’s normalization & QA processes.



Help

About us

Terms of Use

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2025 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.